The comprehensive analysis presented in this study, encompassing organoid survival curves, morphological assessments, cell viability measurements, and DNA damage response profiling, offers a multifaceted perspective on the radiobiological behavior of BRAF-mutant CRC. This evidence concerns the gene BRAF and colorectal carcinoma.